| 000 | 01621 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518073528.0 | ||
| 264 | 0 | _c20200831 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/ciz891 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMacLennan, Calman A | |
| 245 | 0 | 0 |
_aConsensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _c12 2019 |
||
| 300 |
_aS591-S595 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstandards |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 | _aConsensus Development Conferences as Topic |
| 650 | 0 | 4 |
_aDrug Development _xstandards |
| 650 | 0 | 4 |
_aDysentery, Bacillary _xprevention & control |
| 650 | 0 | 4 |
_aEndpoint Determination _xstandards |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aResearch Report |
| 650 | 0 | 4 |
_aShigella _ximmunology |
| 650 | 0 | 4 |
_aShigella Vaccines _ximmunology |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aRiddle, Mark S | |
| 700 | 1 | _aChen, Wilbur H | |
| 700 | 1 | _aTalaat, Kawsar R | |
| 700 | 1 | _aJain, Varsha | |
| 700 | 1 | _aBourgeois, A Louis | |
| 700 | 1 | _aFrenck, Robert | |
| 700 | 1 | _aKotloff, Karen | |
| 700 | 1 | _aPorter, Chad K | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 69 _gno. Suppl 8 _gp. S591-S595 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/ciz891 _zAvailable from publisher's website |
| 999 |
_c30399964 _d30399964 |
||